MEDP Medpace Holdings, Inc.

MEDP Medpace Holdings, Inc.

Healthcare · Diagnostics & Research

Desk view

Watchinglow conviction
Perspectives Biotech Capital Cycle

Market read

Scan convergence 1 scan as of 2026-08-17 1 neutral converging

POC $468.28 · VWAP $507.74 · +17.6% vs 12m avg buyer

uptrend vol: normalchurn: quiet as of

Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)

Coverage

1 related perspective

Watchlists @biotech-capital-cycle@ibb

MEDP Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist MEDP belongs to, members best 30-day change first — MEDP highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@biotech-capital-cycle
View watchlist →
ABCL+73.1% -1.6%1d +19.9%7d TXG+32.6% +3.4%1d -1.1%7d TWST+32.6% +4.9%1d -0.3%7d CRL+27.8% +2.4%1d +3.4%7d ALMR+23.8% -3.1%1d +14.8%7d AVTR+21.9% -1.2%1d -1.6%7d IQV+17.0% +1.9%1d -0.2%7d GENB+15.7% +0.3%1d +6.6%7d CERT+15.4% 0.0%1d -0.9%7d RGEN+14.8% +1.3%1d +3.6%7d SDGR+13.6% -1.1%1d -7.4%7d A+12.9% -0.1%1d -0.2%7d ABSI+11.3% +0.7%1d +2.5%7d MEDP+11.0% +3.2%1d -0.9%7d WAT+10.5% -1.1%1d -1.0%7d TMO+10.0% -0.5%1d -2.3%7d MTD+8.2% -0.1%1d -0.6%7d RXRX+5.8% -1.6%1d -5.2%7d RVTY+5.5% -0.6%1d +0.1%7d ILMN+3.5% +1.2%1d +0.7%7d XBI+3.4% +1.4%1d +1.0%7d FTRE+1.9% +4.0%1d -4.6%7d SLP+0.7% +0.1%1d +0.1%7d ICLR-0.3% +3.9%1d +2.0%7d DHR-0.6% +0.1%1d -3.2%7d BRKR-1.0% -0.1%1d +2.4%7d TEM-1.6% -0.9%1d -6.2%7d SEER-6.5% -2.4%1d -5.5%7d VKTX-9.3% +1.3%1d -2.2%7d QSI-9.8% 0.0%1d -6.3%7d DNA-12.5% +1.9%1d -9.4%7d AGIO-15.1% +0.2%1d +3.1%7d PACB-16.0% +5.2%1d +4.3%7d LAB-23.6% -4.2%1d -11.5%7d QTRX-24.6% +12.7%1d +21.2%7d CDXS-29.0% +1.9%1d +7.4%7d NAUT-49.4% -1.1%1d +2.3%7d
@ibb
View watchlist →
ABCL+73.1% -1.6%1d +19.9%7d TXG+32.6% +3.4%1d -1.1%7d TWST+32.6% +4.9%1d -0.3%7d REGN+19.1% +0.3%1d -0.3%7d NTRA+15.8% +1.4%1d -1.4%7d ARGX+14.8% +16.0%1d +14.1%7d AMGN+14.5% +1.0%1d +0.5%7d RVMD+13.9% +4.1%1d +2.5%7d CRSP+13.6% +1.4%1d +1.6%7d SDGR+13.6% -1.1%1d -7.4%7d PTGX+12.6% +2.3%1d +5.9%7d BMRN+11.8% -1.1%1d -3.3%7d ABSI+11.3% +0.7%1d +2.5%7d MEDP+11.0% +3.2%1d -0.9%7d IONS+7.8% +2.4%1d +3.0%7d NKTR+6.5% -0.5%1d -2.9%7d NTLA+6.2% +1.5%1d +0.6%7d VRTX+6.2% +1.9%1d -1.6%7d SRPT+5.6% +0.4%1d +5.9%7d INCY+5.3% +2.8%1d +1.6%7d KYMR+4.9% +3.4%1d +11.8%7d MRNA+4.3% +1.8%1d +7.7%7d ILMN+3.5% +1.2%1d +0.7%7d GILD+3.5% +0.4%1d +4.4%7d IBRX+3.1% +4.6%1d +5.7%7d BIIB+1.5% -0.3%1d +1.0%7d BNTX+0.1% -1.6%1d -1.3%7d ICLR-0.3% +3.9%1d +2.0%7d BEAM-1.6% +1.3%1d -0.6%7d TEM-1.6% -0.9%1d -6.2%7d COGT-3.1% -0.2%1d -8.7%7d EDIT-4.7% +0.7%1d +0.7%7d LEGN-7.2% +1.4%1d -0.1%7d RARE-10.8% -1.4%1d -2.6%7d PACB-16.0% +5.2%1d +4.3%7d ALNY-16.0% -1.8%1d +3.5%7d QTRX-24.6% +12.7%1d +21.2%7d

Desk commentary

Authored analysis and challenge notes tied to MEDP.

1

Next earnings MEDP reports in 62 days Oct 19

Last report Jul 22

Medpace's Q2 2026 print read as a beat: American Banking News (2026-07-28) reports the stock reaching a new 52-week high on "better-than-expected earnings," and MarketBeat (2026-07-28) logged price-target hikes to $609 (Truist, up from $462, Hold maintained) and $624 (Baird, Neutral maintained) in the print's wake.

full note →

Against street estimates

How MEDP's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 9 quarters · newest report Jul 22 · projection Aug 17

Result
Jul 22 4.004.25+6.2%Beat
Apr 22 3.964.28+8.2%Beat
Feb 9 4.234.67+10.5%Beat
Oct 22 '25 3.573.86+8.1%Beat
Jul 21 '25 3.003.10+3.5%Beat
Apr 21 '25 3.073.67+19.6%Beat
Feb 10 '25 3.123.68+18.1%Beat
Oct 21 '24 2.873.01+5.2%Beat

News (last pull)

Headlines about MEDP from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 20 days ago · Jul 29

MEDP research tape

11 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.

scan Monster Scan — 2026-08-17 scan Monster Scan — 2026-08-14 scan Monster Scan — 2026-08-13 scan Monster Scan — 2026-08-12 scan Monster Scan — 2026-08-08
Types
Aug 17 Scan Monster Scan
005930.KS298040.KS5991.T6779.TAAMIAAOIABBNYABCL +4 more
Aug 14 Scan Monster Scan
005930.KS298040.KS5991.T6779.TAAMIAAOIABBNYABCL +4 more
Aug 13 Scan Monster Scan
005930.KS298040.KS5991.T6779.TAAMIAAOIABBNYABCL +4 more
Aug 12 Scan Monster Scan
005930.KS298040.KS5991.T6779.TAAMIAAOIABBNYABCL +4 more
Aug 8 Scan Monster Scan
005930.KS298040.KS5991.T6779.TAALAAMIAAOIABBNY +4 more
Jul 31 Scan Monster Scan
005930.KS298040.KS5991.T6779.TAAMIAAOIABBNYABSI +4 more
Jul 28 Scan Monster Scan
005930.KS298040.KS5991.T6779.TAAMIAAOIABBNYABSI +4 more
Jul 25 Scan Monster Scan
005930.KS298040.KS5991.T6779.TAAMIAAOIABBNYABSI +4 more
Jul 22 Catalyst MEDP earnings
MEDP
Jun 4 Deep Dive MEDP (Medpace Holdings)
MEDP#biotech-capital-cycle
Jun 4 Market Signal Biotech Funding Gate
XBIIBBARKGMEDPIQVTMO#biotech-capital-cycle